Search clinical trials for: Immunotherapy

Total 4024 results

Pfizer

Completed

Trial Of Erlotinib With Or Without PF-3512676 In Advanced Non Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

United States
The Cleveland Clinic

Completed

External Beam Radiotherapy and Zevalin for Management of Indolent B-Cell Non-Hodgkin's Lymphoma

Lymphoma, B-Cell

United States
Laboratorios Leti, S.L.

Completed

Immunotherapy With Depigmented and Polymerized Allergen Extract of Olea Europaea (GPIT)

Allergy | Rhinoconjunctivitis

Spain
Laboratorios Leti, S.L.

Completed

Immunotherapy With Depigmented and Polymerized Allergen Extract of Phleum Pratense

Asthma | Rhinitis, Allergic, Seasonal | Conjunctivitis, Allergic

Spain
Radboud University Medical Center

Completed

Carcinoembryonic Antigen-loaded Dendritic Cells in Advanced Colorectal Cancer Patients

Colorectal Cancer | Liver Metastases

Netherlands
Seoul National University Hospital

Completed

Efficacy of Sublingual Immunotherapy in Polysensitized Allergic Rhinitis Patients

Allergic Rhinitis

Korea, Republic of
Erasmus Medical Center

Completed

Dendritic Cell-based Immunotherapy in Mesothelioma

Malignant Pleural Mesothelioma

Netherlands
Qingdao University

Unknown

Cytokine Induced Killer Cells Stimulated by DC Immunotherapy for Renal Cell Carcinoma

Renal Cell Carcinoma

China
Circassia Limited
Adiga Life Sciences, Inc.

Completed

Safety of ToleroMune House Dust Mite (HDM) to Treat House Dust Mite Allergy in HDM Allergic Subjects With Rhinoconjunctivitis

Allergy

Canada
Circassia Limited
Adiga Life Sciences, Inc.

Completed

Safety of ToleroMune Ragweed to Treat Ragweed Allergy in Ragweed Allergic Subjects With Rhinoconjunctivitis

Allergy

Canada
Stallergenes Greer
Quintiles, Inc.

Completed

Safety and Tolerability Study of Ragweed SLIT Tablets

Rhinitis, Allergic, Seasonal | Ragweed Pollen Allergy

Hungary
Affiris AG

Completed

Tolerability and Safety of Subcutaneous Administration of Affitope AD01 in Mild to Moderate Alzheimer's Disease

Alzheimer's Disease

Austria
Affiris AG

Completed

Tolerability and Safety of Subcutaneous Administration of AFFITOPE AD02 in Mild to Moderate Alzheimer's Disease

Alzheimer's Disease

Austria
Circassia Limited
Cetero Research, San Antonio; Adiga Life Sciences, Inc.

Completed

Cat-PAD Exposure Chamber Study

Cat Allergy

Canada
Medical University of Vienna

Unknown

Safety Study of Combined Immunotherapy With Trastuzumab and Cetuximab in Patients With Metastatic Breast Cancer

Metastatic Breast Cancer

Austria
Fred Hutchinson Cancer Center

Completed

Cellular Adoptive Immunotherapy in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndromes That Relapsed After Donor Stem Cell Transplant

Myelodysplastic Syndromes | Leukemia

United States
Dendreon

Completed

Immunotherapy With APC8015 (Sipuleucel-T, Provenge) for Asymptomatic, Metastatic, Hormone-Refractory Prostate Cancer

Hormone-Refractory Prostate Cancer
Dendreon

Completed

Provenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy

Prostate Cancer

United States, Canada
University Hospital, Limoges

Completed

Interest of Flow Cytometry for the Diagnosis, the Follow up and Specific Immunotherapy (SIT) Arrest of Hymenoptera Venom Allergy (Cytoven)

Allergy

France
Transgene

Completed

Immunotherapy With TG4040 in Treatment-naïve Patients Chronically Infected With Hepatitis C Virus

Hepatitis C, Chronic

France
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

No longer available

Emergency Use of Adoptive Immunotherapy With CMV-Specific T Cells After Donor Bone Marrow Transplant of an Infant With Immunodeficiency Syndrome and CMV Infection

Infection | Precancerous/Nonmalignant Condition

United States
University of Zurich

Completed

Frequency of Hymenoptera-stings in Patients Under Allergen-Specific Immunotherapy (SIT) (ZU-HVA-001)

Hymenoptera Sting Allergy

Switzerland
ALK-Abelló A/S
Cetero Research, San Antonio

Completed

Exposure Chamber Trial With Cat Immunotherapy

Cat Allergy

Canada
University of South Florida

Completed

Systemic Reactions to Allergen Immunotherapy Amd Skin Testing (chackos)

SYSTEMIC REACTION

United States
EVE Medical Systems Ltd.
Semmelweis University

Unknown

Role of Hypersensitivity to Female Sex Hormones in Women With Unexplained Recurrent Pregnancy Loss

Abortion, Recurrent

Hungary
Mannkind Corporation

Completed

Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-MT) for Patients With Melanoma.

Advanced Melanoma | Stage III and IV Melanoma

United States
Fred Hutchinson Cancer Center

Completed

Immunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell Transplantation

Cancer

United States
Allergy Therapeutics

Completed

Safety, Immunological Effect and Efficacy of the Combined Application of MPL and Grass Pollen Allergen

Type I Hypersensitivity

Germany
Allergy Therapeutics

Completed

Assessment of Residual Allergenicity of Tree (Birch, Hazel, and Alder) Pollen Allergoid Using Skin Prick Testing

Type I Hypersensitivity

Canada
Allergy Therapeutics

Completed

Assessment of the Contribution of Monophosphoryl Lipid A (MPL) to a Tree Pollen Allergy Vaccine

Type I Hypersensitivity

Canada
Allergy Therapeutics

Completed

Efficacy and Safety/Tolerability of Ragweed MATA MPL

Type I Hypersensitivity

Canada, United States
Allergy Therapeutics

Completed

Induction of Immunogenicity With Different Doses of Grass MATA in Subjects Allergic to Grass and Rye Pollen

Type I Hypersensitivity

United States
Allergy Therapeutics

Completed

Assessment of Residual Allergenicity of Ragweed Pollen Allergoid With Monophosphoryl Lipid A (MPL) Using Skin Prick Testing

Type I Hypersensitivity

Canada
Allergy Therapeutics

Completed

Efficacy and Safety/Tolerability of Grass MATA MPL

Type I Hypersensitivity

United States, Canada, United Kingdom, Austria
Allergy Therapeutics

Completed

Follow-up Investigation of Efficacy of Ragweed MATAMPL,and Placebo in Patients With Ragweed-induced Seasonal Allergic Rhinitis

Type I Hypersensitivity

Canada
Allergy Therapeutics

Completed

Investigation of Efficacy and Safety of Ragweed MATAMPL, Pollinex-R and Placebo in Patients With Ragweed Allergy

Type I Hypersensitivity

Canada
Allergy Therapeutics

Completed

Induction of Immunogenicity With Different Doses of TreeMATA in Subjects Allergic to Tree Pollen

Type I Hypersensitivity

United States
EVE Medical Systems Ltd.

Unknown

Evaluation of Safety/Efficacy of Diagnostic Skin Test Panel and Desensitization Hormone Kit for Treatment of Premenstrual Syndrome (PMS)

Premenstrual Syndrome

Israel
EVE Medical Systems Ltd.

Unknown

Evaluation of Efficacy/Safety of EVE-PMS Skin Test Panel

Premenstrual Syndrome

Israel
Allergy Therapeutics

Completed

Assessment of Residual Allergenicity of Grass/Rye Pollen Allergoid Using Skin Prick Testing

Type I Hypersensitivity

United States
University of Genova

Completed

Sublingual Immunotherapy In Alternaria-Induced Rhinitis

Allergic Rhinitis (w/w Asthma) Due to Alternaria Alternata

Italy
West Penn Allegheny Health System
Pennsylvania Allergy and Asthma Research Foundation

Completed

Pilot Study of Allergy Immunotherapy and Prevention of Viral Respiratory Infections

Allergy | Perennial Allergic Rhinitis | Seasonal Allergic Rhinitis

United States
Affiris AG

Completed

Long-term Safety and Tolerability of AFFITOPE AD01

Alzheimer's Disease

Austria
Affiris AG

Completed

Long-term Safety and Tolerability of AFFITOPE AD02

Alzheimer's Disease

Austria
University Hospital Tuebingen
Paul Ehrlich Institute, Langen, Germany

Completed

Vaccination of Metastatic Breast Cancer Patients With a CD80-modified Allogeneic Cancer Cell Line (KS2422) (KS2422-vacc)

Metastatic Breast Cancer

Germany
Clinica Universidad de Navarra, Universidad de...

Unknown

Phase II Study With Immunotherapy With Dendritic Cells and Tumor Infiltrating Lymphocytes in Solid Tumors

Melanoma | Renal Cell Carcinoma | Carcinoma, Hepatocellular

Spain
Fred Hutchinson Cancer Center

Completed

Cellular Adoptive Immunotherapy in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer

Ovarian Cancer | Peritoneal Cavity Cancer

United States
Circassia Limited
Adiga Life Sciences, Inc.

Completed

Safety of Cat-PAD to Treat Cat Allergy in Cat Allergic Subjects With Controlled Asthma

Cat Allergy

Canada
Artu Biologicals

Completed

Efficacy and Safety of Grass Pollen Sublingual Immunotherapy

Allergic Rhinoconjunctivitis

Bulgaria, Lithuania, Czech Republic, Germany, Hungary, Netherlands, Slovakia
Artu Biologicals

Completed

Long-term Efficacy and Safety Study With Oralgen Grass Pollen

Allergic Rhinoconjunctivitis

Bulgaria, Lithuania, Czech Republic, Germany, Hungary, Netherlands, Slovakia

3

Subscribe